New VOYAGER PAD Analysis Confirms Consistent Benefit of XARELTO ® (rivaroxaban) Plus Aspirin Following Lower Extremity Revascularization (LER)
TITUSVILLE, NJ, March 5, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from a new prespecified analysis from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefits of the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) over standard of care (aspirin alone), demonstrating consistent benefit at 30 days, 90 days and up to three years following LER in patients with PAD. Lower extremity revascularization, also called peripheral revascularization, is a procedure that restores blood flow in blocked arteries or veins. This analysis of ...
Source: Johnson and Johnson - March 5, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Hypertensive Disorders of Pregnancy Linked to Risk for CVD
FRIDAY, Feb. 24, 2023 -- Genetic evidence indicates that hypertensive disorders of pregnancy (HDPs) are associated with an increased risk for atherosclerotic cardiovascular disease, specifically coronary artery disease and ischemic stroke, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 24, 2023 Category: Pharmaceuticals Source Type: news
Pioglitazone Use Linked to Reduced Dementia Risk in T2DM
THURSDAY, Feb. 16, 2023 -- For patients with diabetes mellitus (DM), pioglitazone use is associated with a reduced risk for dementia, especially in those with a history of ischemic heart disease or stroke, according to a study published online Feb.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 16, 2023 Category: Pharmaceuticals Source Type: news
'Mini' strokes must be treated 'within hours' to prevent a major attack - signs to spot
A transient ischaemic attack , which is also known as a "mini" stroke, can often precede a full stroke - acting as a warning sign. (Source: Daily Express - Health)
Source: Daily Express - Health - February 16, 2023 Category: Consumer Health News Source Type: news
Similar Effect of Early, Late BP Reduction in Stroke: CATIS-2 Similar Effect of Early, Late BP Reduction in Stroke: CATIS-2
In patients with acute ischemic stroke who have not received thrombolysis or thrombectomy, early versus late antihypertensive treatment did not reduce the likelihood of death and major disability.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - February 15, 2023 Category: Emergency Medicine Tags: Cardiology News Source Type: news
Novel Celery Seed –Derived Drug May Improve Stroke Outcomes Novel Celery Seed –Derived Drug May Improve Stroke Outcomes
The drug, butylphthalide, was associated with better outcomes after ischemic stroke after thrombolysis or endovascular therapy.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - February 15, 2023 Category: Cardiology Tags: Cardiology News Source Type: news
Janssen Data at ASCO GU Support Ambition to Transform Treatment of Prostate and Bladder Cancer Through Precision Medicine and Early Intervention
RARITAN, N.J., February 13, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced plans to present more than 20 abstracts featuring seven oncology therapies from its robust portfolio and pipeline at the annual American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, taking place in San Francisco on February 16-18. Building on more than a decade of leadership in the development of medicines for people diagnosed with GU cancers, Janssen will present data demonstrating its ambition to advance patient-centered treatment through precision medicine, real-world evidence a...
Source: Johnson and Johnson - February 13, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Tenecteplase Noninferior to Alteplase for Ischemic Stroke: TRACE-2 Tenecteplase Noninferior to Alteplase for Ischemic Stroke: TRACE-2
988192Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - February 13, 2023 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news
Early DAPT Improves Outcomes for Strokes With No Other Tx Options
(MedPage Today) -- DALLAS -- Adding tirofiban (Aggrastat) to aspirin for dual antiplatelet therapy (DAPT) within 24 hours of acute ischemic stroke improved outcomes for patients who weren't candidates for thrombolytic or endovascular treatment... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 12, 2023 Category: Cardiology Source Type: news
CATIS-2: Delayed Antihypertension Tx for Acute Ischemic Stroke Still an Option
(MedPage Today) -- DALLAS -- Antihypertensive treatment could wait for 7 days following an acute ischemic stroke (AIS), so long as the patient has no comorbidities that warrant the emergency reduction of their blood pressure (BP).
In the CATIS... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - February 11, 2023 Category: Neurology Source Type: news
Tirofiban Improves Outcomes for Strokes With No Other Tx Options
(MedPage Today) -- DALLAS -- Tirofiban (Aggrastat) improved acute ischemic stroke outcomes for patients who weren't candidates for thrombolytic or endovascular treatment, according to a phase III trial from China.
The glycoprotein IIb/IIIa inhibitor... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 11, 2023 Category: Cardiology Source Type: news
Thrombectomy Benefits Stroke With Large Core Volumes: SELECT2 Thrombectomy Benefits Stroke With Large Core Volumes: SELECT2
A new international trial has shown large benefits of thrombectomy in patients with ischemic strokes with a large core volume, which should lead to a change in clinical practice.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 10, 2023 Category: Pathology Tags: Cardiology News Source Type: news
DAPT Underused for Minor Stroke, TIA
(MedPage Today) -- DALLAS -- Fewer than half of patients were prescribed a dual antiplatelet therapy (DAPT) regimen after minor stroke or transient ischemic attack (TIA), a population-based registry showed.
For strokes with an NIH Stroke Scale... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 9, 2023 Category: Cardiology Source Type: news
Tenecteplase on Par With Alteplase, Randomized Trial Affirms
(MedPage Today) -- DALLAS -- Tenecteplase (TNKase) did as good a job at ischemic stroke thrombolysis as did alteplase (Activase) for patients presenting within 4.5 hours of symptom onset in the randomized TRACE-2 trial from China.
The proportion... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 9, 2023 Category: Cardiology Source Type: news
ASA: Sex Differences Seen in Use of Dual Antiplatelet Therapy After Minor Stroke
THURSDAY, Feb. 9, 2023 -- Dual antiplatelet therapy (DAPT) is underused following transient ischemic attack (TIA) and minor acute ischemic stroke (AIS), particularly in women, according to a study presented at the annual American Stroke Association... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 9, 2023 Category: Pharmaceuticals Source Type: news
